0HC7 Stock Overview
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 2/6 |
Past Performance | 1/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
Albemarle Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$119.96 |
52 Week High | US$247.27 |
52 Week Low | US$108.52 |
Beta | 1.63 |
1 Month Change | -1.01% |
3 Month Change | -20.00% |
1 Year Change | -46.16% |
3 Year Change | -20.03% |
5 Year Change | 42.18% |
Change since IPO | 4.85% |
Recent News & Updates
Recent updates
Shareholder Returns
0HC7 | GB Chemicals | GB Market | |
---|---|---|---|
7D | -5.1% | 3.1% | 2.2% |
1Y | -46.2% | -31.6% | 3.7% |
Return vs Industry: 0HC7 underperformed the UK Chemicals industry which returned -31.6% over the past year.
Return vs Market: 0HC7 underperformed the UK Market which returned 3.7% over the past year.
Price Volatility
0HC7 volatility | |
---|---|
0HC7 Average Weekly Movement | 8.2% |
Chemicals Industry Average Movement | 7.3% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 11.3% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0HC7's share price has been volatile over the past 3 months.
Volatility Over Time: 0HC7's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1887 | 9,000 | Jerry Masters | https://www.albemarle.com |
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.
Albemarle Corporation Fundamentals Summary
0HC7 fundamental statistics | |
---|---|
Market cap | US$13.99b |
Earnings (TTM) | US$1.57b |
Revenue (TTM) | US$9.62b |
8.9x
P/E Ratio1.5x
P/S RatioIs 0HC7 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
0HC7 income statement (TTM) | |
---|---|
Revenue | US$9.62b |
Cost of Revenue | US$8.42b |
Gross Profit | US$1.20b |
Other Expenses | -US$376.57m |
Earnings | US$1.57b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 13.39 |
Gross Margin | 12.45% |
Net Profit Margin | 16.36% |
Debt/Equity Ratio | 42.0% |
How did 0HC7 perform over the long term?
See historical performance and comparison